Back to previous section

Abingdon confirms five projects already underway at Wisconsin site

Abingdon Health said five contract development projects are already underway at its newly opened Madison, Wisconsin facilities on Monday, as it accelerated its US expansion and prepares to add high-throughput manufacturing capacity.

  • Abingdon Health
  • 01 September 2025 14:42:53
Abingdon Health

Source: Sharecast

The AIM-traded lateral flow diagnostics specialist launched its US contract development and manufacturing organisation (CDMO) operations in April, and had since signed agreements covering areas including pharmaceutical monitoring, veterinary testing, infectious disease diagnostics for animals and humans, and feasibility work on novel nanoparticles with a leading US university.

All projects were being run from Madison with support from Abingdon’s UK sites.

The company said the wins highlighted growing demand for its end-to-end CDMO platform, which it said offered clients the ability to take an idea “through to commercial success” and provided optionality for manufacturing in both the US and UK.

Phase two of the Madison expansion would see the installation of high-throughput equipment replicating UK facilities, enabling customers to scale production under identical conditions on either side of the Atlantic.

“These contract awards validate our decision to expand our CDMO operations into the US and we anticipate further expansion in Madison, Wisconsin, as projects and products move through the development cycle,” said Dr Chris Hand, executive chairman of Abingdon Health.

“It is pleasing to see our US customers recognise the value of our comprehensive CDMO platform.

“We deliver end-to-end diagnostic solutions from initial concept through to market launch, and these contract wins illustrate strong confidence in our approach from US-based clients.”

At 1412 BST, shares in Abingdon Health were up 11.43% at 5.85p.

Reporting by Josh White for Sharecast.com.

N/A

Isin: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Communify

The information contained on this website and in the tools, data, prices, news, charts, fundamentals and other content made available through it is provided by Communify Europe Limited, unless expressly stated otherwise.

The information is provided for informational purposes only. It does not constitute investment advice, a personal recommendation, investment research, a research recommendation, an invitation or inducement to engage in investment activity, or a recommendation to buy, sell or hold any share, company, fund, investment vehicle or other financial instrument. Communify Europe Limited does not assess the suitability or appropriateness of any investment for any user.

The information is based on sources that Communify Europe Limited considers reliable. However, Communify Europe Limited does not guarantee that the information is accurate, complete, current, uninterrupted, secure or error-free. Prices, quotes and trades may be delayed by at least fifteen minutes unless expressly stated to be provided in real time.

Past performance is not an indicator of future performance. Communify Europe Limited does not guarantee the return of any investment or the performance of any security, company, investment vehicle, index, underlying asset or market. The value of investments may rise or fall, and investors may lose all or part of the amount invested.

To the extent permitted by applicable law, Communify Europe Limited will not be liable for any loss or damage arising from use of the information contained on this website. Nothing in this notice excludes or limits liability for fraud, death or personal injury caused by negligence, breach of the duty to provide services with reasonable care and skill, or any other liability that cannot be excluded or limited under applicable law. Terms and conditions apply.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2026 Refinitiv, an LSEG business. All rights reserved.